Structural basis of pharmacological chaperoning for human β-galactosidase

GM1-gangliosidosis and Morquio B are rare lysosomal storage diseases associated with a neurodegenerative disorder or dwarfism and skeletal abnormalities, respectively. These diseases are caused by deficiencies in the lysosomal enzyme human β-Galactosidase (β-Gal), frequently related to misfolding and subsequent endoplasmic reticulum-associated degradation (ERAD) due to mutations in the β-Gal gene. Pharmacological chaperone (PC) therapy is a newly developed molecular therapeutic approach by using small molecule ligands of the mutant enzyme that are able to promote the correct folding, prevent ERAD and promote trafficking to the lysosome. Here, we present the enzymological properties of wild-type human β-Gal and two representative mutations in GM1 gangliosidosis Japanese patients (R201C and I51T). We have also evaluated the PC effect of two competitive inhibitors of β-Gal. Moreover, we determined the crystal structures of β-Gal in complex with these compouds and two structurally related analogues to elucidate the detailed atomic view of the recognition mechanism. All compounds bind to the active site of β-Gal with the sugar moiety making hydrogen bonds to active site residues. Moreover, the binding affinity, the enzyme selectivity and the PC potential are strongly affected by the mono or bicyclic structure of the core as well as the orientation, the nature and the length of the exocyclic substituent. These results provide understanding on the mechanism of action of β-Gal selective chaperoning by newly developed PC compounds.

Crystal structure analysis of dipeptidyl amino peptidase from P. mexicana WO24.

Dipeptidyl aminopeptidase (DAP or DPP, EC 3.4.14) catalyses the removal of dipeptides from the amino termini of peptides and proteins. In microorganisms, we have reported the identification, purification, and characterization of DAP BI, DAP BII, DAP BIII, and DAP IV (bacterial DPP4), POP from Pseudoxanthomonas mexicana WO24, and demonstrated that DAP BI, DAP BIII, DAP IV and POP belong to the POP family and they are classified into the clan SC, family S9 in the MEROPS database. On the basis of the enzymological data we obtained, we proposed that bacterial DAPs should be classified in a manner different from that of mammalian DPPs, except for the DAP IV. The DAP IV liberates dipeptides from the free amino terminus and has a specificity for both proline and hydroxyproline residues in the penultimate position of peptides. Here, we report the first structure of the bacterial DPP IV (P. mexicana WO24 DAP IV) complexed with an inhibitor at 2.2 Å resolution. The subunit structure is composed of two domains, the N-terminal eight-bladed β-propeller domain and the C-terminal alpha/beta/alpha sandwich catalytic domain. These structural features are conserved with clan SC S9 family. However, the N-terminal domain contains a unique helix region that extends over the active site acting as a lid, gating substrate or product access. Based upon the structural data, as well as molecular modeling, a model suggesting that the unique helix region is conserved in some kind of bacterial DPP4s except for mammalian DPP4s and some bacterial DPP4s. Some asaccharolytic and anaerobic bacteria can be used protein or peptides as an energy source. Therefore, these bacteria secrete many types of proteases and peptidases. Especially, the elucidation of degradation mechanisms of collagen, including proline and hydroxyproline, are very important from the point of view of host tissue breakdown in pathogens. Our findings suggest that different ligand recognition mechanisms from the bacterial DPP IV to mammalian DPP4 raise the possibility of an antimicrobial development targeting DPP IV from bacteria.

Crystal Structure analyses of dipeptidyl aminopeptidase BII from P. mexicana WO24.

The peptidase family S46 that contains the dipeptidyl aminopeptidase BII (DAP BII) from Pseudoxanthomonas mexicana WO24 is the only exopeptidase family in clan PA peptidases. Our present phylogenetic and experimental studies indicated that the catalytic triad of DAP BII is composed of His 86, Asp 224 and Ser 657 and implied that unknown large helical domains involved in exopeptidase activity[1]. However, three-dimensional structure of a family S46 peptidase has not yet been reported. Thus, the crystal structure of DAP BII is essential not only to understand the catalytic mechanism of family S46 peptidases but also to clarify the structural origin of the exo-type peptidase activities of these enzymes. Recently, we have successfully crystallized the DAP BII and collected X-ray diffraction data to 2.3 Å resolution from the crystal. This crystal belonging to space group P2₁2₁2₁, with unit-cell parameters a = 76.55 Å, b = 130.86 Å, c = 170.87 Å[2]. Structural analysis by the multi-wavelength anomalous diffraction method is underway[3]. Here, we report the first crystallization and structural analysis of the DAP BII from P. mexicana WO24 as family S46 peptidase. Other enzymes that belong to this family are DPP7 and DPP11 from Porphyromonas gingivalis, DPP11 from Porphyromonas endodontalis (periodontal pathogen) and DPP11 from Shewanella putrefaciens (multidrug resistance associated opportunistic pathogen). These gram-negative bacterial pathogens are known to asaccharolytic. Especially, Porphyromonas gingivalis is known to utilize dipeptides, instead of free amino acids, as energy source and cellular material. Since S46 peptidases are not found in mammals, we expect our study will be useful for the discovery of specific inhibitors to S46 peptidases from these pathogens.

High pressure crystallization and crystallography of glucose isomerase

Crystallization of protein is still a "bottleneck" for the three-dimensional (3D) structure analysis of a protein molecule. Therefore, the study on the acceleration of the crystallization is important. Visuri et al. repoted, for the first time, that the crystallization of glucose isomerase (GI) crystals was significantly enhanced with increasing pressure [1], while they did not discuss further effects of pressure on the crystallization. We measured solubilities, growth rates of a crystal face, step velocities and two-dimensional (2D) nucleation rates, three-dimensional (3D) nucleation rates of the GI crystal under high pressure. From these results, we found the negative molar volume change of crystallization delta V, the decrease in a step ledge surface energy and the increase in a step kinetic coefficient with increasing pressure. Activation volume of crystallization delta V‡ was discussed and the absolute value of it was almost half of that of delta V [2]. X-ray crystallography is also very important to study how the three dimensional structure of protein is related to its function under high pressure at atomic level. Kundrot et al. analyzed the crystal structure of lysozyme at 100 MPa using a beryllium (Be) cell. The crystal was prepared under 0.1 MPa. Charron et al. reported that thaumatin crystals grown under 150 MPa were analyzed under 0.1 MPa. Although Kundrot et al. concluded that the protein structure under high pressure was compressed, they could not estimate the influence of the bond structure of the crystal at 0.1 MPa on the compressed structure. In Charron's case, the thaumatin structures in crystals prepared under 0.1 MPa and 150 MPa were almost identical, when they did X-ray analyses of both crystals at 0.1 MPa. From these two results, we considered that compression of the crystals was reversible. We conducted both Kundrot's and Charron's methods for GI using a stand-alone type Be vessel [3]. We found that (1) GI molecule was reversibly compressed under high pressure, (2) the distributions of water sites around GI molecules were almost identical in the range of pressures from 0.1 to 100 MPa.

Visualizing soaking process of protein crystal

Time-resolved visualization of the soaking process of tetragonal lysozyme crystal was performed by synchrotron radiation microtomography. Mother liquor containing hexachloroplatinate was introduced into a capillary bearing lysozyme crystals to visualize crystals undergoing soaking. The platinum distribution was first observed in the superficial layer of crystal and then gradually penetrated into the crystal core. The crystal structure of the platinum derivative in each soaking period was determined by time-resolved crystallography. A total of five platinum sites were identified in Bijvoet difference maps. These sites were classified into two groups on the basis of the time dependence of electron density development. A soaking process model consisting of binding-rate-driven and equilibrium-driven layers is proposed to describe the results. This study suggests that the structures of soaked crystals vary depending on the crystal position from which diffractions were taken.

Building brain network in electron density map determined by micro-CT

In macromolecular crystallography, an electron density distribution is traced to build a model of the target molecule. We applied this method to model building for electron density maps of a brain network. Human cerebral tissue was stained with heavy atoms [1]. The sample was then analyzed at the BL20XU beamline of SPring-8 to obtain a three-dimensional map of X-ray attenuation coefficients representing the electron density distribution. Skeletonized wire models were built by placing and connecting nodes in the map [2], as shown in the figure below. The model-building procedures were similar to those reported for crystallographic analyses of macromolecular structures, while the neuronal network was automatically traced by using a Sobel filter. Neuronal circuits were then analytically resolved from the skeletonized models. We suggest that X-ray microtomography along with model building in the electron density map has potential as a method for understanding three-dimensional microstructures relevant to biological functions.